|
|
|
|
||
Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD I continue to hold some ACAD shares, and the relative strength since its minirun from the $38s. I also am trying to free up some funds for adding to this position. These CNS plays have a good future, as more data and treatment options arrive on the scene. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
17084 | Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD | sphericalkutz | 2 | 9/23/2020 12:42:02 PM |